rs104894207
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The NM_001814.6(CTSC):c.755A>T(p.Gln252Leu) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000139 in 1,435,528 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 14/24 in silico tools predict a damaging outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001814.6 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- Papillon-Lefevre diseaseInheritance: AR, Unknown Classification: DEFINITIVE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
- Haim-Munk syndromeInheritance: Unknown, AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics
- ectodermal dysplasia syndromeInheritance: AR Classification: STRONG Submitted by: Illumina
- periodontitis, aggressive 1Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CTSC | NM_001814.6 | c.755A>T | p.Gln252Leu | missense_variant, splice_region_variant | Exon 5 of 7 | ENST00000227266.10 | NP_001805.4 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CTSC | ENST00000227266.10 | c.755A>T | p.Gln252Leu | missense_variant, splice_region_variant | Exon 5 of 7 | 1 | NM_001814.6 | ENSP00000227266.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000139 AC: 2AN: 1435528Hom.: 0 Cov.: 28 AF XY: 0.00000279 AC XY: 2AN XY: 715948 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Papillon-Lefèvre syndrome Pathogenic:2
Variant summary: CTSC c.755A>T (p.Gln252Leu) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251320 control chromosomes. c.755A>T has been reported in the literature in multiple individuals affected with Papillon-Lefevre syndrome (e.g., Toomes_1999, Hamon_2016, SanchezKlose_2021). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 26607765, 34932608, 10581027). ClinVar contains an entry for this variant (Variation ID: 7291). Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
Papillon-Lefèvre syndrome;C1855627:Haim-Munk syndrome;C4551681:Periodontitis, aggressive 1 Pathogenic:1
This sequence change replaces glutamine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 252 of the CTSC protein (p.Gln252Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with Papillon–Lefevre syndrome (PMID: 10581027, 18294227, 34932608; internal data). ClinVar contains an entry for this variant (Variation ID: 7291). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
not provided Pathogenic:1
The Q252L likely pathogenic variant in the CTSC gene has been reported previously in the homozygous state in association with Papillon-Lefevre syndrome (Toomes et al., 1999; Schacher et al., 2006; Noack et al., 2008). The variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). Q252L is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. In summary, we consider this variant to be likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at